萨拉·布伦纳成为FDA代理专员, 在罗伯特·卡利夫博士退出后加紧推进. Sara Brenner becomes FDA's acting commissioner, stepping up after Dr. Robert Califf's exit.

美国食品和药物管理局的医疗器械部门的官员萨拉·布伦纳 (Sara Brenner) 已被任命为FDA的代理专员, Sara Brenner, an official in the FDA's medical device division, has been appointed as the acting commissioner of the FDA, stepping in after Dr. Robert Califf's departure. 自2019年以来一直在FDA工作的布伦纳将领导,直到参议院确认约翰霍普金斯外科医生马蒂·马卡里,他被特朗普总统提名为永久职位. Brenner, who has been with the FDA since 2019, will lead until the Senate confirms Johns Hopkins surgeon Marty Makary, nominated by President Trump for the permanent role. 布伦纳还参与了FDA对COVID-19大流行的反应. Brenner was also involved in the FDA's response to the COVID-19 pandemic.